会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • Composition for preventing and treating hepatoma
    • 用于预防和治疗肝癌的组合物
    • US20070117864A1
    • 2007-05-24
    • US10572945
    • 2004-12-24
    • Kazumi YagasakiYutaka MiuraDaiki MiuraRisto SanttiNiina Saarinen
    • Kazumi YagasakiYutaka MiuraDaiki MiuraRisto SanttiNiina Saarinen
    • A61K31/365
    • A61K36/15A23L33/105A23V2002/00A61K31/365C07D307/33A23V2200/308A23V2250/21
    • The present invention provides a liver cancer prophylactic and therapeutic composition, and the present invention relates to a liver cancer prophylactic and therapeutic composition characterized in that this composition contains compounds that have a hepatoma proliferation inhibiting effect as active ingredients, these compounds comprising enterolactone (ENL) or plant lignan precursors of the same; a liver cancer prophylactic and therapeutic drug characterized in that this drug comprises compounds that have a hepatoma proliferation inhibiting effect, these compounds being enterolactone (ENL) or plant lignan precursors of the same, and a pharmacologically permissible carrier component; and a functional food product material characterized in that this food product material is formed by mixing compounds that have a hepatoma proliferation inhibiting effect, these compounds being enterolactone (ENL) or plant lignan precursors of the same as functional components with a food product material.
    • 本发明提供肝癌预防和治疗组合物,本发明涉及肝癌预防和治疗组合物,其特征在于该组合物含有作为活性成分具有肝癌增殖抑制作用的化合物,这些化合物包括肠内酯(ENL) 或植物木酚素前体; 一种肝癌预防和治疗药物,其特征在于该药物包括具有肝癌增殖抑制作用的化合物,这些化合物是肠内酯(ENL)或其植物木酚素前体,以及药理学上允许的载体组分; 以及功能食品,其特征在于,通过混合具有肝癌增殖抑制作用的化合物,这些化合物是肠内酯(ENL)或与功能组分相同的植物木酚素前体与食品材料形成。
    • 3. 发明申请
    • PLATE, DETERMINATION KIT, AND DETERMINATION METHOD FOR IMMUNOASSAY
    • 板,测定工具包和免疫测定方法
    • US20070141596A1
    • 2007-06-21
    • US11550949
    • 2006-10-19
    • Kazumi YagasakiIsao Miyazaki
    • Kazumi YagasakiIsao Miyazaki
    • C12Q1/70C12Q1/68
    • G01N33/56988B01L3/5085G01N33/54306G01N2469/20
    • Disclosed herein are a plate capable of determining the presence or absence of an anti-virus antibody with higher accuracy, a determination kit equipped with the plate, and a determination method using the determination kit for immunoassay. The determination method is as follows. First, a liquid specimen is fed into each of the predetermined wells of the plate fixed two or more kinds of antigens derived from a specific virus. Each well carries one of the two or more kinds of antigens on the inner surface thereof. Then, a reagent containing colored particles 1 carrying an anti-IgG antibody is fed into each of the wells containing the liquid specimen. When an antibody bound to the antigen is detected in a predetermined number or more of the wells, a living body is determined to be infected with the virus.
    • 本文公开了能够以更高的精度确定抗病毒抗体的存在或不存在的板,配备有该板的测定试剂盒和使用该测定试剂盒进行免疫测定的测定方法。 测定方法如下。 首先,将液体样品送入板的每个预定孔中,固定来自特定病毒的两种或更多种抗原。 每个孔在其内表面上携带两种或更多种抗原中的一种。 然后,将含有携带抗IgG抗体的着色颗粒1的试剂加入到含有液体样品的每个孔中。 当在预定数量以上的孔中检测到与抗原结合的抗体时,确定活体被病毒感染。